Search Results - "CROBACH, L. F. S. J"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection by KOLKMAN, J. J., TAN, T. G., POOL, M. OUDKERK, KLEEF, W. A. VAN, GERAEDTS, A. A. M., TIMMERMAN, R. J., CROBACH, L. F. S. J., NICOLAI, J. J., WOLFF, A. A. C., LAAN, J. VAN DER

    Published in Alimentary pharmacology & therapeutics (01-12-1997)
    “…Aim: To compare the efficacy of ranitidine bismuth citrate plus clarithromycin (RBC–C) vs. omeprazole plus amoxycillin (OME–AMO) in the cure of Helicobacter…”
    Get full text
    Journal Article
  3. 3

    Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemia by MEIJER, J. L, CROBACH, L. F. S. J, JANSEN, J. B. M. J, LAMERS, C. B. H. W

    Published in Digestive diseases and sciences (01-03-1994)
    “…This study was undertaken to determine whether the synthetic prostaglandin E2 analog enprostil is able to inhibit basal and postprandial hypergastrinemia…”
    Get full text
    Journal Article
  4. 4

    Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion by BIEMOND, I, CROBACH, L. F. S. J, JANSEN, J. B. M. J, LAMERS, C. B. H. W

    Published in European journal of clinical pharmacology (01-01-1989)
    “…A study has been done in 10 male healthy volunteers of the effect of oral omeprazole 20 mg daily for 3 days on the serum concentrations of Pepsinogens A and C…”
    Get full text
    Journal Article
  5. 5

    Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin by Crobach, L F, Jansen, J B, Lamers, C B

    “…Omeprazole, a substituted benzimidazole inhibitor of the gastric H+/K+-ATPase, is a potent and long-acting antisecretory drug. Because of its high potency and…”
    Get more information
    Journal Article
  6. 6

    Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man by Meijer, J L, Jansen, J B, Crobach, L F, Biemond, I, Lamers, C B

    Published in Gut (01-09-1993)
    “…Whether the long acting somatostatin analogue SMS 201-995 (octreotide, Sandostatin) could inhibit the basal and meal stimulated hypergastrinaemia and…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers by Biemond, I, Crobach, LF, Jansen, JB, Lamers, CB

    Published in British journal of clinical pharmacology (01-04-1990)
    “…1. Omeprazole, a substituted benzimidazole inhibitor of the gastric H+/K(+)‐APT‐ase, was administered orally at a dose of 20 mg in the morning of 3 consecutive…”
    Get full text
    Journal Article
  8. 8

    Effect of intermittent weekend therapy with omeprazole on basal and postprandial serum gastrin concentrations in patients with duodenal ulcer by Crobach, L F, Jansen, J B, Lamers, C B

    Published in Clinical pharmacology and therapeutics (01-06-1988)
    “…We have studied the effect on serum gastrin concentrations of weekly 3-day courses of 20 mg/day omeprazole followed by a 4-day period without medication…”
    Get more information
    Journal Article
  9. 9

    Radioimmunoassay of human pepsinogen A and pepsinogen C by Biemond, I, Jansen, J B, Crobach, L F, Kreuning, J, Lamers, C B

    “…We describe the development of radioimmunoassays to measure both human pepsinogen A and pepsinogen C concentrations in serum. The antibodies were raised in…”
    Get more information
    Journal Article